Comparative Effectiveness of All Available Treatments for Metastatic Hormone-Sensitive Prostate Cancer: A Network Meta-analysis

Am J Ther. 2020 Sep/Oct;27(5):e541-e543. doi: 10.1097/MJT.0000000000001008.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Androgen Antagonists / pharmacology
  • Androgen Antagonists / therapeutic use*
  • Androstenes / pharmacology
  • Androstenes / therapeutic use
  • Antineoplastic Agents, Hormonal / pharmacology
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Docetaxel / pharmacology
  • Docetaxel / therapeutic use
  • Drug Resistance, Neoplasm
  • Humans
  • Male
  • Network Meta-Analysis
  • Progression-Free Survival
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / mortality
  • Randomized Controlled Trials as Topic
  • Survival Rate
  • Systematic Reviews as Topic

Substances

  • Androgen Antagonists
  • Androstenes
  • Antineoplastic Agents, Hormonal
  • Docetaxel
  • abiraterone